In addition, the authors extrapolated nine drugs from the DRUGBANK database that could reduce the expression levels of TMPRSS2. In particular, two of these drugs (Paracetamol and Curcumin) are currently being administered to alleviate some symptoms in COVID-19 patients [25]. Here, TMPRSS2 is linked to COVID-19.